• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期新冠的脑雾和肌肉疼痛与急性感染期间从呼吸道清除新冠病毒RNA的时间延长有关。

Long COVID brain fog and muscle pain are associated with longer time to clearance of SARS-CoV-2 RNA from the upper respiratory tract during acute infection.

作者信息

Antar Annukka A R, Yu Tong, Demko Zoe O, Hu Chen, Tornheim Jeffrey A, Blair Paul W, Thomas David L, Manabe Yukari C

出版信息

medRxiv. 2023 Jan 19:2023.01.18.23284742. doi: 10.1101/2023.01.18.23284742.

DOI:10.1101/2023.01.18.23284742
PMID:36711478
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9882625/
Abstract

The incidence of long COVID is substantial, even in people who did not require hospitalization for acute COVID-19. The pathobiological mechanisms of long COVID and the role of early viral kinetics in its development are largely unknown. Seventy-three non-hospitalized adult participants were enrolled within approximately 48 hours of their first positive SARS-CoV-2 RT-PCR test, and mid-turbinate nasal and saliva samples were collected up to 9 times within the first 45 days after enrollment. Samples were assayed for SARS-CoV-2 using RT-PCR and additional test results were abstracted from the clinical record. Each participant indicated the presence and severity of 49 long- COVID symptoms at 1-, 3-, 6-, 12-, and 18-months post-COVID-19 diagnosis. Time from acute COVID-19 illness onset to SARS-CoV-2 RNA clearance greater or less than 28 days was tested for association with the presence or absence of each of 49 long COVID symptoms at 90+ days from acute COVID-19 symptom onset. Brain fog and muscle pain at 90+ days after acute COVID-19 onset were negatively associated with viral RNA clearance within 28 days of acute COVID-19 onset with adjustment for age, sex, BMI ≥ 25, and COVID vaccination status prior to COVID-19 (brain fog: aRR 0.46, 95% CI 0.22-0.95; muscle pain: aRR 0.28, 95% CI 0.08-0.94). This work indicates that at least two long COVID symptoms - brain fog and muscle pain - at 90+ days from acute COVID-19 onset are specifically associated with longer time to clearance of SARS-CoV-2 RNA from the upper respiratory tract.

摘要

长期新冠的发病率相当高,即使在那些因急性新冠病毒病(COVID-19)无需住院治疗的人群中也是如此。长期新冠的病理生物学机制以及早期病毒动力学在其发展过程中的作用在很大程度上尚不清楚。73名未住院的成年参与者在首次SARS-CoV-2逆转录聚合酶链反应(RT-PCR)检测呈阳性后的约48小时内入组,并在入组后的前45天内最多采集9次中鼻甲鼻拭子和唾液样本。使用RT-PCR对样本进行SARS-CoV-2检测,并从临床记录中提取其他检测结果。每位参与者在COVID-19诊断后的1个月、3个月、6个月、12个月和18个月时指出49种长期新冠症状的存在情况和严重程度。对从急性COVID-19发病到SARS-CoV-2 RNA清除时间大于或小于28天的情况进行检测,以确定其与急性COVID-19症状出现90多天后49种长期新冠症状中每种症状的存在与否之间的关联。在对年龄、性别、BMI≥25以及COVID-19之前的新冠疫苗接种状况进行调整后,急性COVID-19发病90多天后的脑雾和肌肉疼痛与急性COVID-19发病后28天内的病毒RNA清除呈负相关(脑雾:调整后相对危险度[aRR]为0.46,95%置信区间[CI]为0.22 - 0.95;肌肉疼痛:aRR为0.28,95%CI为0.08 - 0.94)。这项研究表明,急性COVID-19发病90多天后至少两种长期新冠症状——脑雾和肌肉疼痛——与上呼吸道中SARS-CoV-2 RNA清除时间较长存在特定关联。

相似文献

1
Long COVID brain fog and muscle pain are associated with longer time to clearance of SARS-CoV-2 RNA from the upper respiratory tract during acute infection.长期新冠的脑雾和肌肉疼痛与急性感染期间从呼吸道清除新冠病毒RNA的时间延长有关。
medRxiv. 2023 Jan 19:2023.01.18.23284742. doi: 10.1101/2023.01.18.23284742.
2
Long COVID brain fog and muscle pain are associated with longer time to clearance of SARS-CoV-2 RNA from the upper respiratory tract during acute infection.长新冠脑雾和肌肉疼痛与急性感染期间上呼吸道 SARS-CoV-2 RNA 清除时间延长有关。
Front Immunol. 2023 Apr 28;14:1147549. doi: 10.3389/fimmu.2023.1147549. eCollection 2023.
3
Relationship between acute SARS-CoV-2 viral clearance with Long COVID Symptoms: a cohort study.急性SARS-CoV-2病毒清除与长期新冠症状之间的关系:一项队列研究。
medRxiv. 2024 Jul 5:2024.07.04.24309953. doi: 10.1101/2024.07.04.24309953.
4
Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial.COVID-19 门诊患者的早期抗病毒治疗(FLARE):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Mar 8;22(1):193. doi: 10.1186/s13063-021-05139-2.
5
Delayed rise of oral fluid antibodies, elevated BMI, and absence of early fever correlate with longer time to SARS-CoV-2 RNA clearance in an longitudinally sampled cohort of COVID-19 outpatients.在一组纵向采样的新冠门诊患者队列中,口腔液抗体延迟上升、体重指数升高以及早期无发热与新冠病毒RNA清除时间延长相关。
medRxiv. 2021 Mar 3:2021.03.02.21252420. doi: 10.1101/2021.03.02.21252420.
6
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
7
Delayed Rise of Oral Fluid Antibodies, Elevated BMI, and Absence of Early Fever Correlate With Longer Time to SARS-CoV-2 RNA Clearance in a Longitudinally Sampled Cohort of COVID-19 Outpatients.在一组纵向采样的新冠门诊患者队列中,口腔液抗体延迟出现、体重指数升高以及早期无发热与新冠病毒RNA清除时间延长相关。
Open Forum Infect Dis. 2021 Apr 16;8(6):ofab195. doi: 10.1093/ofid/ofab195. eCollection 2021 Jun.
8
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
9
Association between brain fog, cardiac injury, and quality of life at work after hospitalization due to COVID-19.因 COVID-19 住院后,大脑雾感、心脏损伤与工作生活质量之间的关系。
Med Pr. 2024 Mar 22;75(1):3-17. doi: 10.13075/mp.5893.01428. Epub 2024 Feb 27.
10
Brain Fog and Quality of Life at Work in Non-Hospitalized Patients after COVID-19.新冠康复后非住院患者的脑雾和工作生活质量
Int J Environ Res Public Health. 2022 Oct 6;19(19):12816. doi: 10.3390/ijerph191912816.